These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22685216)

  • 21. Nicotine glucuronidation and the human UDP-glucuronosyltransferase UGT2B10.
    Kaivosaari S; Toivonen P; Hesse LM; Koskinen M; Court MH; Finel M
    Mol Pharmacol; 2007 Sep; 72(3):761-8. PubMed ID: 17576790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction and Verification of Physiologically Based Pharmacokinetic Models for Four Drugs Majorly Cleared by Glucuronidation: Lorazepam, Oxazepam, Naloxone, and Zidovudine.
    Docci L; Umehara K; Krähenbühl S; Fowler S; Parrott N
    AAPS J; 2020 Oct; 22(6):128. PubMed ID: 33033903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential metabolism of sesamin by cytochrome P450 and UDP-glucuronosyltransferase in human liver.
    Yasuda K; Ikushiro S; Kamakura M; Munetsuna E; Ohta M; Sakaki T
    Drug Metab Dispos; 2011 Sep; 39(9):1538-45. PubMed ID: 21622626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resveratrol (trans-resveratrol, 3,5,4'-trihydroxy-trans-stilbene) glucuronidation exhibits atypical enzyme kinetics in various protein sources.
    Iwuchukwu OF; Nagar S
    Drug Metab Dispos; 2008 Feb; 36(2):322-30. PubMed ID: 17991766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human UDP-glucuronosyltransferase expression in insect cells: ratio of active to inactive recombinant proteins and the effects of a C-terminal his-tag on glucuronidation kinetics.
    Zhang H; Patana AS; Mackenzie PI; Ikushiro S; Goldman A; Finel M
    Drug Metab Dispos; 2012 Oct; 40(10):1935-44. PubMed ID: 22782802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
    Kaji H; Kume T
    Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors.
    Walsky RL; Bauman JN; Bourcier K; Giddens G; Lapham K; Negahban A; Ryder TF; Obach RS; Hyland R; Goosen TC
    Drug Metab Dispos; 2012 May; 40(5):1051-65. PubMed ID: 22357286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal glucuronidation metabolism may have a greater impact on oral bioavailability than hepatic glucuronidation metabolism in humans: a study with raloxifene, substrate for UGT1A1, 1A8, 1A9, and 1A10.
    Mizuma T
    Int J Pharm; 2009 Aug; 378(1-2):140-1. PubMed ID: 19486934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation.
    Hanioka N; Naito T; Narimatsu S
    Chemosphere; 2008 Dec; 74(1):33-6. PubMed ID: 18990428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereoselective glucuronidation of carvedilol in human liver and intestinal microsomes.
    Hanioka N; Tanaka S; Moriguchi Y; Narimatsu S
    Pharmacology; 2012; 90(3-4):117-24. PubMed ID: 22814440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of UDP-glucuronosyltransferase isoforms involved in hepatic and intestinal glucuronidation of phytochemical carvacrol.
    Dong RH; Fang ZZ; Zhu LL; Ge GB; Yang L; Liu ZY
    Xenobiotica; 2012 Oct; 42(10):1009-16. PubMed ID: 22559213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucuronidation of curcuminoids by human microsomal and recombinant UDP-glucuronosyltransferases.
    Hoehle SI; Pfeiffer E; Metzler M
    Mol Nutr Food Res; 2007 Aug; 51(8):932-8. PubMed ID: 17628876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucuronidation of anti-HIV drug candidate bevirimat: identification of human UDP-glucuronosyltransferases and species differences.
    Wen Z; Martin DE; Bullock P; Lee KH; Smith PC
    Drug Metab Dispos; 2007 Mar; 35(3):440-8. PubMed ID: 17151190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance.
    Soars MG; Burchell B; Riley RJ
    J Pharmacol Exp Ther; 2002 Apr; 301(1):382-90. PubMed ID: 11907196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucuronidation of linoleic acid diols by human microsomal and recombinant UDP-glucuronosyltransferases: identification of UGT2B7 as the major isoform involved.
    Jude AR; Little JM; Czernik PJ; Tephly TR; Grant DF; Radominska-Pandya A
    Arch Biochem Biophys; 2001 May; 389(2):176-86. PubMed ID: 11339806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms.
    Zhu L; Ge G; Zhang H; Liu H; He G; Liang S; Zhang Y; Fang Z; Dong P; Finel M; Yang L
    Drug Metab Dispos; 2012 Mar; 40(3):529-38. PubMed ID: 22180045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism.
    Picard N; Ratanasavanh D; Prémaud A; Le Meur Y; Marquet P
    Drug Metab Dispos; 2005 Jan; 33(1):139-46. PubMed ID: 15470161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiologically based pharmacokinetic modeling of intestinal first-pass metabolism of CYP3A substrates with high intestinal extraction.
    Gertz M; Houston JB; Galetin A
    Drug Metab Dispos; 2011 Sep; 39(9):1633-42. PubMed ID: 21632965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo small intestinal metabolism of CYP3A and UGT substrates in preclinical animals species and humans: species differences.
    Komura H; Iwaki M
    Drug Metab Rev; 2011 Nov; 43(4):476-98. PubMed ID: 21859377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of the human UDP-glucuronosyltransferases involved in the glucuronidation of combretastatin A-4.
    Aprile S; Del Grosso E; Grosa G
    Drug Metab Dispos; 2010 Jul; 38(7):1141-6. PubMed ID: 20375181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.